These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 36996137)
1. LALAPG variant of the Human Contraception Antibody (HCA) reduces Fc-mediated effector functions while maintaining sperm agglutination activity. Mausser E; Nador E; Politch JA; Pauly MR; Marathe JG; Moench TR; Zeitlin L; Whaley KJ; Anderson DJ PLoS One; 2023; 18(3):e0282147. PubMed ID: 36996137 [TBL] [Abstract][Full Text] [Related]
2. Production and characterization of a human antisperm monoclonal antibody against CD52g for topical contraception in women. Baldeon-Vaca G; Marathe JG; Politch JA; Mausser E; Pudney J; Doud J; Nador E; Zeitlin L; Pauly M; Moench TR; Brennan M; Whaley KJ; Anderson DJ EBioMedicine; 2021 Jul; 69():103478. PubMed ID: 34256345 [TBL] [Abstract][Full Text] [Related]
3. Hexavalent sperm-binding IgG antibody released from vaginal film for development of potent on-demand nonhormonal female contraception. Shrestha B; Vincent K; Schaefer A; Zhu Y; Vargas G; Motamedi M; Swope K; Morton J; Simpson C; Pham H; Brennan MB; Pauly MH; Zeitlin L; Bratcher B; Whaley KJ; Moench TR; Lai SK Proc Natl Acad Sci U S A; 2021 Nov; 118(48):. PubMed ID: 34815336 [TBL] [Abstract][Full Text] [Related]
4. Platform-Specific Fc Nador E; Xia C; Santangelo PJ; Whaley KJ; Costello CE; Anderson DJ Antibodies (Basel); 2024 Mar; 13(1):. PubMed ID: 38534207 [TBL] [Abstract][Full Text] [Related]
5. Engineering sperm-binding IgG antibodies for the development of an effective nonhormonal female contraception. Shrestha B; Schaefer A; Zhu Y; Saada J; Jacobs TM; Chavez EC; Olmsted SS; Cruz-Teran CA; Vaca GB; Vincent K; Moench TR; Lai SK Sci Transl Med; 2021 Aug; 13(606):. PubMed ID: 34380769 [TBL] [Abstract][Full Text] [Related]
6. Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease. van Erp EA; Luytjes W; Ferwerda G; van Kasteren PB Front Immunol; 2019; 10():548. PubMed ID: 30967872 [TBL] [Abstract][Full Text] [Related]
7. ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study. Thurman AR; Moench TR; Hoke M; Politch JA; Cabral H; Mausser E; Nador E; Morton J; Hamorsky K; Swope K; Bratcher B; Anderson DJ; Whaley KJ Am J Obstet Gynecol; 2023 Jun; 228(6):716.e1-716.e12. PubMed ID: 36870409 [TBL] [Abstract][Full Text] [Related]
8. Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody. Gehlert CL; Rahmati P; Boje AS; Winterberg D; Krohn S; Theocharis T; Cappuzzello E; Lux A; Nimmerjahn F; Ludwig RJ; Lustig M; Rösner T; Valerius T; Schewe DM; Kellner C; Klausz K; Peipp M Front Immunol; 2022; 13():957874. PubMed ID: 36119088 [TBL] [Abstract][Full Text] [Related]
9. Changes in cervical mucus that prevent penetration by spermatozoa. Chantler E; Sharma R; Sharman D Symp Soc Exp Biol; 1989; 43():325-36. PubMed ID: 2701482 [TBL] [Abstract][Full Text] [Related]
10. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions. Kinder M; Greenplate AR; Strohl WR; Jordan RE; Brezski RJ MAbs; 2015; 7(3):494-504. PubMed ID: 25933349 [TBL] [Abstract][Full Text] [Related]
12. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations. Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058 [TBL] [Abstract][Full Text] [Related]
13. The investigation of immunological infertility. Jones WR Med J Aust; 1979 Aug; 2(4):188-92. PubMed ID: 390335 [TBL] [Abstract][Full Text] [Related]
14. Engineering tetravalent IgGs with enhanced agglutination potencies for trapping vigorously motile sperm in mucin matrix. Shrestha B; Schaefer A; Chavez EC; Kopp AJ; Jacobs TM; Moench TR; Lai SK Acta Biomater; 2020 Nov; 117():226-234. PubMed ID: 32937206 [TBL] [Abstract][Full Text] [Related]
15. The significance of the Fc part of antispermatozoal antibodies for the shaking phenomenon in the sperm-cervical mucus contact test. Jager S; Kremer J; Kuiken J; Mulder I Fertil Steril; 1981 Dec; 36(6):792-7. PubMed ID: 7308524 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding. Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P MAbs; 2015; 7(4):743-51. PubMed ID: 25970007 [TBL] [Abstract][Full Text] [Related]
18. Development of a novel reporter gene assay to evaluate antibody-dependent cellular phagocytosis for anti-CD20 therapeutic antibodies. Liu C; Yu C; Yang Y; Huang J; Yu X; Duan M; Wang L; Wang J Int Immunopharmacol; 2021 Nov; 100():108112. PubMed ID: 34521023 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to spermatozoa. V. Antibody activity in human cervical mucus. Shulman S; Friedman MR Am J Obstet Gynecol; 1975 May; 122(1):101-5. PubMed ID: 1130439 [TBL] [Abstract][Full Text] [Related]
20. The incidence and influence of antisperm antibodies in infertile human couples on sperm-cervical mucus interactions and subsequent fertility. Menge AC; Medley NE; Mangione CM; Dietrich JW Fertil Steril; 1982 Oct; 38(4):439-46. PubMed ID: 7117571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]